Teriflunomide (Aubagio)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Teriflunomide (Aubagio), covering 2015-03-13 to 2015-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis [Phase 3]